Clinical trial
E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn…
NCT00236197 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00236197 |
|---|---|
| Title | E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers |
| Official title | E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heartburn |
| Intervention type | Drug |
| Interventions | rabeprazole sodium, placebo |
| Enrollment | 619 |
| Start date | Oct 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Jun 1, 2008 |
| First posted | Oct 12, 2005 |
| Last update posted | Nov 11, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: